在放射治疗副作用的管理中使用肉毒素
概括
毒素 (BTx) 在治疗慢性辐射副作用方面表现有前途. 需要进一步的研究来确认其在临床应用中的长期疗效和安全性.
科学领域:
- 在瘤学瘤学.
- 皮肤病学 皮肤病学
- 整形外科 整形外科 整形外科
背景情况:
- 调查毒素 (BTx) 辐射诱导的副作用是一个活跃的研究领域.
- 目前关于BTx对辐射副作用的疗效和安全性的长期临床数据仍然没有确定性.
- 需要研究最佳的BTx应用方法,持续时间和潜在的不良影响.
研究的目的:
- 评估毒素 (BTx) 作为改善治疗慢性放射治疗副作用的美学和功能结果的工具.
主要方法:
- 研究BTx应用的临床研究和实验研究.
- 具体的注射技术和目标应用领域.
主要成果:
- 毒素A型 (BTx-A) 被认为是治疗放射治疗副作用的有效和安全选择.
- 适当的注射技术和注射地点的选择提高了治疗的有效性和安全性.
结论:
- 毒素 (BTx) 为缓解慢性辐射相关副作用提供了潜在的治疗选择.
- 优化BTx治疗方案对于最大化益处和确保患者安全至关重要.
相关概念视频
Directly Acting Muscle Relaxants: Dantrolene and Botulinum Toxin
685
Directly acting muscle relaxants like dantrolene and botulinum toxin (BoNT) have distinct mechanisms and applications. Dantrolene, a hydantoin derivative, acts on the ryanodine receptor (RYR1) in skeletal muscle cells. RYR1 are calcium channels present at the sarcoplasmic reticulum membrane. In response to excitation, they release calcium ions from the sarcoplasmic reticulum to the cytosol. Calcium promotes actin-myosin-mediated contraction of muscles.
The binding of dantrolene to the RYR1...
The binding of dantrolene to the RYR1...
685
Skeletal Muscle Relaxants: Therapeutic Uses
493
Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
493
Skeletal Muscle Relaxants: Adverse Effects
377
Skeletal muscle relaxants are widely used for muscle paralysis and relieving pain following any muscle injury or stiffness. However, depending on the drug type, they can have adverse effects that range from mild to severe. Usually, nondepolarizing neuromuscular blockers have minimal side effects. For example, drugs like d-tubocurarine, cisatracurium, and rocuronium cause hypotension, whereas drugs like baclofen, when stopped abruptly, can lead to the recurrence of spastic conditions.
Unlike...
Unlike...
377
Myasthenia Gravis: Overview and Treatment
1.5K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
1.5K
Direct-Acting Cholinergic Agonists: Therapeutic Uses
772
Direct-acting cholinergic agonists have many therapeutic uses in various medical fields. Choline esters, including acetylcholine, have limited clinical utility due to their non-selectivity and short duration of action. Still, acetylcholine and carbachol are applied topically during ophthalmologic surgery to induce miosis. Pilocarpine, a muscarinic and ganglionic stimulator, effectively treats open-angle glaucoma and alleviates xerostomia and dry mouth caused by radiotherapy or Sjögren...
772
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists
217
5-HT3 receptor antagonists, such as dolasetron, granisetron (Kytril), ondansetron (Zofran), and palonosetron (Axoli), are crucial in managing chemotherapy-induced nausea and vomiting (CINV) and postoperative nausea. These drugs selectively block 5-HT3 receptors in the visceral vagal and spinal afferent nerves, chemoreceptor trigger zone, and the vomiting center. They have a rapid onset of action and can be given as a single dose before chemotherapy. Ondansetron and granisetron, in particular,...
217


